Global Molecular Imaging Market 2022-2028

April 2022 | 88 pages | ID: G2A99912EA0EEN
Gen Consulting Company

Abstracts

Molecular imaging is a field of medical imaging that focuses on imaging molecules of medical interest within living patients. Molecular imaging procedures are non-invasive, safe and painless, and are used to diagnose and manage the treatment of cancer, heart disease, brain disorders such as Alzheimer's and Parkinson's disease, gastrointestinal disorders, lung disorders, bone disorders, kidney and thyroid disorders, and more. According to Gen Consulting Company, the global molecular imaging market is projected to reach USD 12,165 million, recording a CAGR of approximately 5.9 percent from 2022 to 2028.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global molecular imaging market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the molecular imaging industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the component, application, end user, and region. The global market for molecular imaging can be segmented by component: imaging agents, imaging software, imaging systems. Globally, the imaging agents segment made up the largest share of the molecular imaging market. Molecular imaging market is further segmented by application: clinical applications, preclinical research. Based on end user, the molecular imaging market is segmented into: ambulatory surgical centers (ASCs), hospitals, speciality clinics, others. On the basis of region, the molecular imaging market also can be divided into: Asia Pacific, Europe, North America, Rest of the World (RoW).

By component:

• imaging agents
• imaging software
• imaging systems

By application:

• clinical applications
• preclinical research

By end user:

• ambulatory surgical centers (ASCs)
• hospitals
• speciality clinics
• others

By region:

• Asia Pacific
• Europe
• North America
• Rest of the World (RoW)

The imaging systems market is further segmented into magnetic resonance spectroscopy, multimodality imaging, optical imaging, radionuclide imaging, ultrasound molecular imaging. The multimodality imaging segment was the largest contributor to the global molecular imaging market in 2021. Furthermore, the imaging agents market has been categorized into antibodies, aptamers, peptides, small molecules. The peptides segment is estimated to account for the largest share of the global molecular imaging market.

The report also provides a detailed analysis of several leading molecular imaging market vendors that include Bayer AG, Bruker Corporation, Canon Medical Systems Corporation, Cardinal Health, Inc., CMR Naviscan Corporation, DDD-Diagnostic A/S, Digirad Corporation, Esaote SpA, GE Healthcare, Guerbet SA, Koninklijke Philips N.V., Mediso Ltd., MiE Medical Imaging Electronics GmbH, Neusoft Corporation, Novartis International AG, PerkinElmer, Inc., Shimadzu Corporation, Siemens Healthineers AG, Spectrum Dynamics Medical, Inc., United Imaging Healthcare Co., Ltd., Vieworks Co., Ltd., among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report

• To analyze and forecast the market size of the global molecular imaging market.
• To classify and forecast the global molecular imaging market based on component, application, end user, region.
• To identify drivers and challenges for the global molecular imaging market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global molecular imaging market.
• To identify and analyze the profile of leading players operating in the global molecular imaging market.

Why Choose This Report

• Gain a reliable outlook of the global molecular imaging market forecasts from 2022 to 2028 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience

PART 2. METHODOLOGY

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

Introduction
Drivers
Restraints
Impact of COVID-19 pandemic

PART 5. MARKET BREAKDOWN BY COMPONENT

Imaging agents
Imaging software
Imaging systems

PART 6. MARKET BREAKDOWN BY APPLICATION

Clinical applications
Preclinical research

PART 7. MARKET BREAKDOWN BY END USER

Ambulatory surgical centers (ASCs)
Hospitals
Speciality clinics
Others

PART 8. MARKET BREAKDOWN BY REGION

Asia Pacific
Europe
North America
Rest of the World (RoW)

PART 9. KEY COMPANIES

Bayer AG
Bruker Corporation
Canon Medical Systems Corporation
Cardinal Health, Inc.
CMR Naviscan Corporation
DDD-Diagnostic A/S
Digirad Corporation
Esaote SpA
GE Healthcare
Guerbet SA
Koninklijke Philips N.V.
Mediso Ltd.
MiE Medical Imaging Electronics GmbH
Neusoft Corporation
Novartis International AG
PerkinElmer, Inc.
Shimadzu Corporation
Siemens Healthineers AG
Spectrum Dynamics Medical, Inc.
United Imaging Healthcare Co., Ltd.
Vieworks Co., Ltd.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER